Phibro Animal Health Stock Statistic Functions Linear Regression Angle
| PAHC Stock | USD 49.00 -1.07 -2.14% |
| Symbol |
The output start index for this execution was twenty-three with a total number of output elements of thirty-eight. The Linear Regression Angle indicator plots the angel of the trend line for each Phibro Animal Health data point.
Phibro Animal Technical Analysis Modules
Most technical analysis of Phibro Animal help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Phibro from various momentum indicators to cycle indicators. When you analyze Phibro charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Phibro Animal Health Corporation
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey. Phibro Anl operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 1860 people. As a large-cap equity, Phibro Animal is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/E of 11.39, P/B of 6.11, profit margin of 6.29%. Phibro Animal has a market cap of 2.03 B, P/E of 11.39, ROE of 31.8%. 
Raphi Shpitalnik ยท Junior Member of Macroaxis Editorial Board
Methodology
Unless otherwise specified, financial data for Phibro Animal Health is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Phibro (USA Stocks:PAHC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We use public filings and market reference sources with disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR as reference inputs. Data may be normalized and can be delayed. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Phibro Animal Health is covered by 4 analysts. 2 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Goldman Sachs, UBS Investment Research, Bank of America Securities, RBC Capital Markets, Jefferies, among others. Updates may occur throughout the day.
Phibro Stock is Curated By:
Raphi Shpitalnik ยท Junior Member of Macroaxis Editorial BoardSome investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Phibro Animal in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Phibro Animal's short interest history, or implied volatility extrapolated from Phibro Animal options trading.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested over 20 shares | |
 | Dividend Beast Invested over 40 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Social Domain Invested few shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Marketing Invested few shares | |
 | Video Games Invested few shares | |
 | Investor Favorites Invested over 200 shares |
More Resources for Phibro Stock Analysis
Understanding Phibro Animal Health typically begins with financial statements and long-term trend review. Key ratios help frame profitability, efficiency, and growth context for Phibro Animal Health Stock. Selected reports below provide context for Phibro Stock:Phibro Animal has a market cap of 2.03 B, operating margin of 14.71%, ROE of 31.8%. Use Your Equity Center to explore allocation context. This includes a position in Phibro Animal Health within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. Analysis related to Phibro Animal should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Quarterly Earnings Growth 7.52 | Dividend Share 0.48 | Earnings Share 2.24 | Revenue Per Share | Quarterly Revenue Growth 0.209 |
The market value of Phibro Animal Health is measured differently than book value, which reflects Phibro accounting equity. Phibro Animal's market capitalization is 2.03 B. With a P/B ratio of 6.11, the market values Phibro Animal well above its book equity. Enterprise value stands at 2.73 B. Intrinsic value is an estimate of underlying worth, separate from trading price and book value. The valuation process compares these measures for perspective.
Note that Phibro Animal's intrinsic value and market price are different measures derived from different inputs. For Phibro Animal, key inputs include a P/E ratio of 11.39, a P/B ratio of 6.11, a profit margin of 6.29%, and ROE of 31.8%. By contrast, market price reflects the level where buyers and sellers transact.